During the past decade, Northern Centre for Cancer Treatment at Newcastle General Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 12 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Centre for Cancer Treatment at Newcastle General Hospital" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Medical Research Council" with 5 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Centre for Cancer Treatment at Newcastle General Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "OSI Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Northern Centre for Cancer Treatment at Newcastle General Hospital" are "Breast Cancer" (9 trials), "Bladder Cancer" (4 trials), "Lung Cancer" (4 trials), "Melanoma" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Northern Centre for Cancer Treatment at Newcastle General Hospital" in a lesser frequency.

Most popular intervention types in "Northern Centre for Cancer Treatment at Newcastle General Hospital" are "Drug" (55 trials), "Procedure" (13 trials), "Radiation" (13 trials), "Biological" (12 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (10 trials), "adjuvant therapy" (7 trials), "capecitabine" (7 trials), "cisplatin" (7 trials) and "cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Northern Centre for Cancer Treatment at Newcastle General Hospital" are 48 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Centre for Cancer Treatment at Newcastle General Hospital". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Northern Centre for Cancer Treatment at Newcastle General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Centre for Cancer Treatment at Newcastle General Hospital, 8 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".